Related Experiment Videos

[Arhinencephaly detected by a pitressin-sensitive diabetes insipidus]

Archives Francaises De Pediatrie
|November 1, 1978
PubMed

Insights

A 4-month-old infant with facial malformations experienced severe hypernatremia due to diabetes insipidus. A low osmotic diet, increased water intake, and hydrochlorothiazide successfully normalized sodium levels and promoted growth.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital disorders affecting antidiuretic hormone (ADH) secretion can lead to severe hypernatremia in infants.
  • Cerebral malformations are sometimes associated with endocrine dysfunction.

Observation:

  • A 4-month-old infant presented with significant facial dysmorphism and severe hypernatremia.
  • The hypernatremia was attributed to central diabetes insipidus resulting from a disorder in ADH secretion, linked to underlying cerebral malformations.

Findings:

  • Clofibrate, a medication sometimes used for diabetes insipidus, proved ineffective in managing the infant's hypernatremia.
  • A therapeutic regimen combining a low osmotic residue diet, increased fluid intake, and hydrochlorothiazide administration normalized serum sodium levels.
  • Following treatment, the infant's growth trajectory resumed, indicating successful management of the condition.

Implications:

  • This case highlights the importance of early diagnosis and tailored management strategies for congenital hypernatremia secondary to ADH secretion disorders.
  • A multi-faceted approach involving dietary modification, hydration, and specific pharmacotherapy (hydrochlorothiazide) can be effective when traditional treatments fail.
  • Successful management is crucial for normalizing physiological parameters and supporting normal growth and development in affected infants.

Related Concept Videos